It probably seems counter-intuitive but the very point of the Alcidion products is to NOT lock in clients into a proprietary IT system.....have a read of the article that Nathan Buzza posted up on Linkedin today.
The MIYA products have been 10 years and $15million in development and ALC is only now moving from a development focus to a sales focus and the reason for listing on the ASX recently. MIYA is based on interoptability between existing health IT systems to enable the freeing up health resources to address the 80 billion dollar hole you mention.
This 80 billion dollar hole (or whatever the actual figure may be) actually becomes a selling point for the MIYA products and is also the reason that the US Government introduced legislation compelling hospitals to introduce some forms of health IT including some form of clinical decision support system in the near future or risk removal of Govt funding.
ALC Price at posting:
5.2¢ Sentiment: Buy Disclosure: Held
